Abstract
In specific patient groups, i.e. children or patients with compromised bone quality, the incidence of implant loss of for bone conduction hearing implants is much higher; further implant optimization is, therefore, needed.
The new laser-ablated titanium implant for bone-anchored hearing implantation has an enlarged contact area for osseointegration compared to the standard implant, aiming to improve implant loss rates.
This retrospective multicenter study is the first to assess the performance of this implant in healthy adults 1 year after surgery.
With excellent survival rates, good soft tissue tolerability, and few complications, the implant is safe to use in healthy adults.
This article is protected by copyright. All rights reserved.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.